Sandra McGuigan, Oncology Therapy Lead at Fortrea, shared a post on LinkedIn about a paper
“A patient has experienced an extraordinary 18 years of remission from neuroblastoma, a rare cancer of nerve cells, due to chimeric antigen receptor (CAR) T cell therapy. No further treatments were necessary!
This could potentially be the longest documented remission for a cancer patient treated with CAR-T cell therapy.”
“Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma”
Authors: Che-Hsing Li, Sandhya Sharma, Andras Heczey, Malcolm Brenner, Helen Heslop et al.
